The FDA’s decision on Novavax’s COVID-19 vaccine could come in weeks

The company's protein-based shot has been authorized or approved in several other countries, including the U.K. and Singapore.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.